Naoya Saishu
Plus aucun poste en cours
Profil
Naoya Saishu has been Auditor of M's Science Corp.
since June 2004.
He was President of Chugai USA and Acting Chief Executive Officer of Gen-Probe in the USA, Deputy General Manager of Health Care Division, and Executive Director of the Head of Legal Department at Chugai Pharmaceutical Co. Ltd.
Mr. Saishu received a degree from the Department of Law, Waseda University.
Anciens postes connus de Naoya Saishu
| Sociétés | Poste | Fin |
|---|---|---|
| CHUGAI PHARMACEUTICAL CO., LTD | Corporate Officer/Principal | - |
M's Science Corp.
 M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Comptroller/Controller/Auditor | - |
Formation de Naoya Saishu
| Waseda University | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CHUGAI PHARMACEUTICAL CO., LTD | Health Technology |
| Entreprise privées | 1 |
|---|---|
M's Science Corp.
M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Commercial Services |
